Dublin, Nov. 08, 2024 (GLOBE NEWSWIRE) -- The "Coronary Artery Bypass Graft Surgery Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2024 Update" report has been added to ResearchAndMarkets.com's offering.
The report provides comprehensive information about the Coronary Artery Bypass Graft Surgery pipeline products with comparative analysis of the products at various stages of development and information about the clinical trials which are in progress.
Coronary artery bypass graft surgery devices are used in the surgery to improve blood flow to the obstructed coronary artery. Surgeons use these devices to treat people who have severe coronary heart disease.
Scope
- Extensive coverage of the Coronary Artery Bypass Graft Surgery under development
- The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
- The report reviews the major players involved in the development of Coronary Artery Bypass Graft Surgery and list all their pipeline projects
- The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
- The report provides key clinical trial data of ongoing trials specific to pipeline products
- Recent developments in the segment / industry
Reasons to Buy
- Formulate significant competitor information, analysis, and insights to improve R&D strategies
- Identify emerging players with potentially strong product portfolio and create effective counter strategies to gain competitive advantage
- Identify and understand important and diverse types of Coronary Artery Bypass Graft Surgery under development
- Develop market-entry and market expansion strategies
- Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
- In-depth analysis of the product's current stage of development, territory and estimated launch date
Key Topics Covered:
1 Table of Contents
1.1 List of Tables
1.2 List of Figures
2 Introduction
2.1 Coronary Artery Bypass Graft Surgery Overview
3 Products under Development
3.1 Coronary Artery Bypass Graft Surgery - Pipeline Products by Stage of Development
3.2 Coronary Artery Bypass Graft Surgery - Pipeline Products by Territory
3.3 Coronary Artery Bypass Graft Surgery - Pipeline Products by Regulatory Path
3.4 Coronary Artery Bypass Graft Surgery - Pipeline Products by Estimated Approval Date
3.5 Coronary Artery Bypass Graft Surgery - Ongoing Clinical Trials
4 Coronary Artery Bypass Graft Surgery - Pipeline Products under Development by Companies
4.1 Coronary Artery Bypass Graft Surgery Companies - Pipeline Products by Stage of Development
4.2 Coronary Artery Bypass Graft Surgery - Pipeline Products by Stage of Development
5 Coronary Artery Bypass Graft Surgery Companies and Product Overview
6 Coronary Artery Bypass Graft Surgery- Recent Developments
7 Appendix
Companies Featured
- Amt Medical BV
- ArtiFex Medical GmbH
- Axcelon Biopolymers Corp
- CardioPolymers Inc
- Cardious Inc
- Coromedic Ltd.
- Cytograft Tissue Engineering Inc (Inactive)
- enVVeno Medical Corp
- Graft-Loc Inc.
- H. Lee Moffitt Cancer Center & Research Institute Inc
- Haimai Medical Technology Co Ltd
- iiTech BV
- McGill University
- Medical 21 Inc
- Myocardial Assist Systems and Technology LLC
- Neograft Technologies Inc
- Nordicus Partners Corp
- PetVivo Holdings Inc
- Prekubator TTO
- RegenMedTX LLC
- SeamVad Ltd.
- Surg Solutions SL
- University College London
- University of Arizona
- University of California Davis
- University of California Los Angeles
- Xeltis AG
For more information about this report visit https://www.researchandmarkets.com/r/it71ej
About ResearchAndMarkets.com
ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
